Veradermics
MANE • XNYS • Stock Fundamentals
Veradermics is a biotechnology company in the healthcare sector trading on XNYS, led by CEO Reid Waldman, with a market cap of $4.2B.
Market Cap$4.2B
Net Income TTM-$52.9M
EPS TTM$-39.63
Free Cash Flow TTM-$46.3M
CEOReid Waldman
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
ROE-28.71%
Current Ratio59.12
Cash$168.4M
CapEx TTM$19.0K
Net Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metric
Veradermics FAQ
Common questions about Veradermics
Veradermics (MANE) has a market capitalization of $4.2B and trades on XNYS.